Neuregulin antagonists and use thereof in treating cancer

Details for Australian Patent Application No. 2011218125 (hide)

Owner GENENTECH, INC. THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY

Inventors Jackson, Erica; Sweet-Cordero, Eric Alejandro

Agent Griffith Hack

Pub. Number AU-A-2011218125

PCT Pub. Number WO2011/103242

Priority 61/305,878 18.02.10 US

Filing date 17 February 2011

Wipo publication date 25 August 2011

International Classifications

C07K 14/475 Peptides having more than 20 amino acids

A61K 31/7088 - Compounds having three or more nucleosides or nucleotides

A61K 38/17 Medicinal preparations containing peptides - from animals

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 Antineoplastic agents

C07K 14/71 Peptides having more than 20 amino acids

C12N 15/113 Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

C12N 15/62 Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

19 July 2012 PCT application entered the National Phase

  PCT publication WO2011/103242 Priority application(s): WO2011/103242

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011218126-Optical splicing connectors along with adapters therefor

2011218124-Methods for laser processing arrayed optical fibers and protection element used in said methods